Digital Phenotyping for Retinal Disease

• July 24, 2026

The Promise of Gene Therapy

With phase 3 topline data for sura-vec expected later this year, Arshad M. Khanani, MD, FASRS, reflects on how gene therapy could transform long-term treatment for nAMD.

• by Arshad M. Khanani, MD, MA, FASRS

• July 15, 2026

• 2 min

"Landmark" Dataset Maps Anterior Segment Disease

Moorfields and UCL launch dataset aiming to accelerate research into anterior segment conditions

• July 16, 2026

• 2 min

Can Stem Cell Therapy Slow GA?

Phase 1b data for ASP7317, presented at ASRS, showed a favorable safety profile, encouraging visual acuity findings, and stabilization of geographic atrophy in patients with advanced disease.

• by VIVIENNE HAU, MD, PHD

• July 15, 2026

• 3 min